Varenicline Tablet, Film Coated
Product Images NDC 49884-155

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 49884-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-stru (Varenicline Tablets 1)

FDA Label Image

Figure-1 (Varenicline Tablets 2)

FDA Label Image

Figure-2 (Varenicline Tablets 3)

FDA Label Image

Figure-3 (Varenicline Tablets 4)

Figure-3 (Varenicline Tablets 4)
This appears to be a graph or chart showing the percentage of continuous abstinence in relation to Varenicline 1.0 mg BID (Twice a day) and a Placebo over a period of 8 weeks. The weeks are labeled at the bottom of the chart with corresponding percentage values on the y-axis. This chart may be related to a study on smoking cessation or addiction.*
FDA Label Image

Label-56's Count (Varenicline Tablets 5)

Label-56's Count (Varenicline Tablets 5)
This is a medication called Varenicline, which comes in a film coated tablet form with 0.5mg dosage. The medication guide is to be provided separately to each patient. The tablets should be kept away from children and should be dispensed in child resistant containers. The usual dosage should be referred from the prescribing information. The medicine should be stored at a controlled temperature between 20-25°C. It is manufactured by Par Formulations Private Limited in India and distributed by Par Pharmaceutical in the USA. Mfg. Lic. No.: TNO0002121.*
FDA Label Image

Label-56's Count (Varenicline Tablets 6)

Label-56's Count (Varenicline Tablets 6)
Each film-coated tablet contains 1.71 mg varenicline tartrate equivalent to 1 mg varenicline free base. The usual dosage and further information is available in the accompanying prescribing information. The medication should be dispensed by a pharmacist and the medication guide should be provided separately to each patient. It should be kept out of reach of children and stored in a tight, child-resistant container. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F).*
FDA Label Image

Starting Month Box (Varenicline Tablets 7)

Starting Month Box (Varenicline Tablets 7)
This is a medication guide for Varenicline tablets, probably used to stop smoking cigarettes. The medication contains varenicline tartrate, and the dosage recommended for the first three days and days 4 to 7 are "0.5mg" taken once a day, and from Day 7 to Day 28, "1mg" once a day. The medication needs to be taken in the morning and in the evening with one 0.5mg tablet or one 1mg tablet. This medication guide contains information about the manufacturer and storage of the medication, but not much scientific information about the effects, benefits or side effects of the medication.*
FDA Label Image

Starting Pack (Varenicline Tablets 8)

Starting Pack (Varenicline Tablets 8)
This is a starting pack of Varenicline Tablets, with an NDC of 4884-944.99. No other useful information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.